Ani Pharmaceuticals (ANIP) Net Income towards Common Stockholders (QoQ) (2011 - 2026)
Ani Pharmaceuticals (ANIP) Net Income towards Common Stockholders (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Ani Pharmaceuticals | 1.71 Bn | 1.40 Bn | 143.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.28% |
| Dec 31, 2025 | 4.63% |
| Sep 30, 2025 | 222.68% |
| Jun 30, 2025 | -46.70% |
| Mar 31, 2025 | 243.00% |
| Dec 31, 2024 | 56.53% |
| Sep 30, 2024 | -812.10% |
| Jun 30, 2024 | -115.13% |
| Mar 31, 2024 | 2,276.64% |
| Dec 31, 2023 | -92.14% |
| Sep 30, 2023 | 63.31% |
| Jun 30, 2023 | 465.15% |
| Mar 31, 2023 | 122.22% |
| Dec 31, 2022 | 48.37% |
| Sep 30, 2022 | 41.25% |
| Jun 30, 2022 | 25.35% |
| Mar 31, 2022 | 15.58% |
| Dec 31, 2021 | -447.02% |
| Sep 30, 2021 | 68.47% |
| Jun 30, 2021 | -17,514.81% |